Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: VOLUME

Do you think there is any chance the 10Q might reflect any tax loss carry-overs from CrossFlo's past operations that PTSC could capitalize on? In my delusions (still aflected, I'm afraid), I can envision the possibility that such could be an underlying sweetness to the CrossFlo deal, possibly in a big way.

TIA,

SGE



Share
New Message
Please login to post a reply